GAITHERSBURG, Md. (BUSINESS WIRE) Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company pioneering the development of phage-based therapies to combat bacterial infections, announced today that it has received a $12 million upfront investment from funds managed by Deerfield Management and the AM.
Adaptive Phage Therapeutics Closes on $12 Million Investment in $30 Million Series B1 to Fight Antibiotic Resistant Infections streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
ORANGE Ralph C. Mahar Regional School held one of its semiannual science fairs this week, with projects explaining everything from ice melt corrosion, to sleep’s effect on mood, to the impact of the meat and dairy industries.Chemistry teacher.
Mini Takes The States returned for 2022, but with a difference. TheDetroitBureau.com looks at why it changed along with some of those who participated.
What Do Conspiracy Theories And AI Explainability Have In Common? forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.